Chapter 1 Introduction 1.1 Antibody Array Technologies and Applications 1.2 Protein Phosphorylation, Localization and Function 1.3 Interaction Proteomics and Pathway Building 1.3.1 BMP2 Signaling 1.3.2 The Effect of STI571 on Cell Signaling Chapter 2 Technologies 2.1 Materials 2.1.1 Cell Lines 2.1.2 Chemicals 2.1.3 Antibodies 2.1.4 Protein-Molecular Weight Marker 2.1.5 Apparatus 2.2 Methods 2.2.1 Cell Culture 2.2.2 Cell Numbers and Experimental Format 2.2.3 Cytoplasmic and Nuclear Protein Extracts 2.2.4 Determination of Protein Concentration 2.2.5 Ponceau S Staining 2.2.6 Western Analysis 2.2.7 Immunoprecipitation 2.2.8 Cell Cycle Analysis 2.3 Silver Staining in ArrayTube 2.3.1 Biotinylation of Cellular Proteins 2.3.2 Incubation of Protein Extracts 2.3.3 Silver Staining 2.3.4 Statistical Analysis Chapter 3 New Cytoplasmic and Nuclear BMP2-Signaling Pattern in U937 Cells 3.1 Modulation of Phosphorylation and Localization in BMP2-Treated U937 Cells 3.1.1 Total p-Tyrosine and p-p38, p38 Increased: Increasing Cytoplasm and Nucleus 3.1.2 Total p-ERK and p-JNK Increased: Increasing Cytoplasm and Unchanged Nucleus 3.1.3 Total p-Akt Increased: Increasing Cytoplasm and Decreasing Nucleus 3.1.4 Total p-Smad1, p-Smad2/3, c-Myc and p-STAT3 Unchanged: Decreasing Cytoplasm and Increasing Nucleus 3.1.5 Total p-p70S6 Unchanged: Increasing Cytoplasm and Decreasing Nucleus 3.2 BMP2 Signaling in U937 Cells 3.2.1 BMP2 Activates Akt, ERK and JNK Pathway in U937 Cells 3.2.2 BMP2 Activates Smad1 and Smad2/3 Networks, p38 Network and c-Myc, Tyrosine Network in U937 Cells 3.2.3 BMP2 Inhibits p70S6 Signaling in U937 cells 3.3 BMP2 Signaling Model in U937 Cells Chapter 4 New Cytoplasmic and Nuclear BMP2-Signaling in MCF7 Cells 4.1 Modulation of Phosphorylation and Localization in BMP2-Treated MCF7 Cells 4.1.1 Total p-JNK, p-Smad1, p-Smad2/3, p-p38 and p38 Unchanged: Increasing Cytoplasm and Decreasing Nucleus 4.1.2 p-Tyrosine, p-STAT3, p-ERK and p-p70S6 Increased: Increasing Cytoplasm and Unchanged Nucleus 4.1.3 Total c-Myc Unchanged: Slightly Increasing Nucleus and Slightly Decreasing Cytoplasm 4.1.4 Total p-Akt Unchanged: Unchanged Nucleus and Cytoplasm 4.2 BMP2 Signaling in MCF7 Cells 4.2.1 BMP2 Activates p70S6 and ERK Signaling, Tyrosine and STAT3 Network in MCF7 Cells 4.2.2 BMP2 Inhibits p38, JNK and Smad Signaling in MCF7 Cells 4.2.3 BMP2 Activates c-Myc Signaling in MCF7 Cells 4.3 BMP2 Signaling Model in MCF7 Cells Chapter 5 New Cytoplasmic and Nuclear STI571 Signaling in K562 Cells 5.1 Modulation of Phosphorylation and Localization in STI571-Treated K562 Cells 5.1.1 Total p-Akt and p-p70S6 Decreased: Decreasing Cytoplasm and Nucleus …… Chapter 6 Positive and Negative Co-localized Relationships in Three Treated Cell Lines Chapter 7 Cytoplasmic Signaling in Three Treated Cell Lines Chapter 8 Proteomic Silencing in Treated Human Cancer Cell Lines Chapter 9 Signaling Pathway Setting-up Based on Bioinformatics References